RVL PHARMACEUTICALS PLC (RVLP) Stock Price, Forecast & Analysis
USA - NASDAQ:RVLP - IE00BF2HDL56 - Common Stock
RVLP Key Statistics, Chart & Performance
The current stock price of RVLP is 0.0282 USD. In the past month the price decreased by -71.8%. In the past year, price decreased by -98.37%.
RVLP Latest News, Press Relases and Analysis
RVLP Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| LLY | ELI LILLY & CO | 44.96 | 935.69B | ||
| JNJ | JOHNSON & JOHNSON | 18.67 | 466.81B | ||
| MRK | MERCK & CO. INC. | 10.32 | 227.17B | ||
| PFE | PFIZER INC | 7.97 | 145.04B | ||
| BMY | BRISTOL-MYERS SQUIBB CO | 7.43 | 99.17B | ||
| ZTS | ZOETIS INC | 18.95 | 53.23B | ||
| RPRX | ROYALTY PHARMA PLC- CL A | 9.48 | 22.72B | ||
| VTRS | VIATRIS INC | 4.81 | 13.06B | ||
| ELAN | ELANCO ANIMAL HEALTH INC | 23.81 | 11.36B | ||
| CORT | CORCEPT THERAPEUTICS INC | 89.78 | 8.33B | ||
| AXSM | AXSOME THERAPEUTICS INC | N/A | 6.97B | ||
| LGND | LIGAND PHARMACEUTICALS | 28.63 | 4.09B |
Related stock screener links
About RVLP
Company Profile
RVL Pharmaceuticals Plc engages in the development and commercialization of products for neurology and women's health. The company is headquartered in Bridgewater, New Jersey and currently employs 125 full-time employees. The company went IPO on 2018-10-12. The firm is focused on the commercialization of UPNEEQ, or RVL-1201 (oxymetazoline hydrochloride ophthalmic solution), 0.1%, for the treatment of acquired blepharoptosis, or low-lying eyelid, in adults. The company is focused on growing Upneeq with eye care and medical aesthetic professionals and providing a prescription experience for patients through its pharmacy. RVL Pharmacy dispenses Upneeq only. The firm is also developing Arbaclofen ER tablets for the alleviation of spasticity in multiple sclerosis patients. Its target patient population comprises adults with droopy or low-lying eyelids or acquired ptosis, the majority of whom are female. Its healthcare provider customers include optometrists, ophthalmologists, oculoplastic surgeons, facial plastic surgeons, dermatologists, and practitioners qualified to diagnose and treat acquired blepharoptosis in adults.
Company Info
RVL PHARMACEUTICALS PLC
400 Crossing Boulevard
Bridgewater NEW JERSEY US
Employees: 125
Phone: 19088091300.0
RVL PHARMACEUTICALS PLC / RVLP FAQ
What does RVLP do?
RVL Pharmaceuticals Plc engages in the development and commercialization of products for neurology and women's health. The company is headquartered in Bridgewater, New Jersey and currently employs 125 full-time employees. The company went IPO on 2018-10-12. The firm is focused on the commercialization of UPNEEQ, or RVL-1201 (oxymetazoline hydrochloride ophthalmic solution), 0.1%, for the treatment of acquired blepharoptosis, or low-lying eyelid, in adults. The company is focused on growing Upneeq with eye care and medical aesthetic professionals and providing a prescription experience for patients through its pharmacy. RVL Pharmacy dispenses Upneeq only. The firm is also developing Arbaclofen ER tablets for the alleviation of spasticity in multiple sclerosis patients. Its target patient population comprises adults with droopy or low-lying eyelids or acquired ptosis, the majority of whom are female. Its healthcare provider customers include optometrists, ophthalmologists, oculoplastic surgeons, facial plastic surgeons, dermatologists, and practitioners qualified to diagnose and treat acquired blepharoptosis in adults.
What is the current price of RVLP stock?
The current stock price of RVLP is 0.0282 USD. The price decreased by -32.05% in the last trading session.
Does RVLP stock pay dividends?
RVLP does not pay a dividend.
What is the ChartMill technical and fundamental rating of RVLP stock?
RVLP has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 2 out of 10.
What sector and industry does RVL PHARMACEUTICALS PLC belong to?
RVL PHARMACEUTICALS PLC (RVLP) operates in the Health Care sector and the Pharmaceuticals industry.
Would investing in RVL PHARMACEUTICALS PLC be a good decision?
This depends on your investment goals. Check the Technical and Fundamental Analysis tabs for insights on RVLP.
What is the employee count for RVLP stock?
RVL PHARMACEUTICALS PLC (RVLP) currently has 125 employees.
RVLP Technical Analysis
RVLP Fundamental Analysis
ChartMill assigns a fundamental rating of 2 / 10 to RVLP. RVLP has a bad profitability rating. Also its financial health evaluation is rather negative.
RVLP Financial Highlights
Over the last trailing twelve months RVLP reported a non-GAAP Earnings per Share(EPS) of -0.7. The EPS increased by 27.84% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -79.93% | ||
| ROE | -418.14% | ||
| Debt/Equity | 0 |
RVLP Forecast & Estimates
9 analysts have analysed RVLP and the average price target is 3.21 USD. This implies a price increase of 11293.62% is expected in the next year compared to the current price of 0.0282.
For the next year, analysts expect an EPS growth of 27.9% and a revenue growth -28.9% for RVLP